Sichere und passende Pharmakotherapie in der Kinderanästhesie

Sichere und passende Pharmakotherapie bei Kindern erfordert die Kenntnis von altersgruppenspezifischen Besonderheiten bezüglich der Pharmakologie und der Dosierung von Medikamenten. Zusätzlich müssen Aspekte der Medikamentensicherheit beachtet werden. Diese Übersicht zeigt Grundprinzipien auf und bespricht die wichtigsten Fakten, weitere Recherchen in pädiatrischen Datenbanken werden empfohlen (www.kinderformularium.de).

Abstract

Safe and appropriate pharmacotherapy in children requires knowledge of age-group-specific features regarding pharmacology and drug dosing. In addition, aspects of medication safety must be considered. This review highlights basic principles and discusses key facts; further research in paediatric databases is recommended (www.kinderformularium.de).

Schlüsselwörter

Kinderanästhesie - Patientensicherheit - Medikamentensicherheit - paediatric anaesthesia - patient safety - drug safety

• Literatur

• 1 Kearns GL, Abdel-Rahman SM, Alander SW. et al. Developmental pharmacology – drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349: 1157-1167
• 2 Banner jr. W, Vernon DD, Dean JM. et al. Nonlinear dopamine pharmacokinetics in pediatric patients. J Pharmacol Exp Ther 1989; 249: 131-133
• 3 Papp JG. Autonomic responses and neurohumoral control in the human early antenatal heart. Basic Res Cardiol 1988; 83: 2-9
• 4 Zahn J, Wimmer S, Rödle W. et al. Development and evaluation of a web-based paediatric drug information system for Germany. Pharmacy 2021; 9: 8
• 5 Le A, Patel S. Extravasation of noncytotoxic drugs: a review of the literature. Ann Pharmacother 2014; 48: 870-886
• 6 Chidambaran V, Costandi A, D’Mello A. Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs 2015; 29: 543-563
• 7 Jöhr M. Pharmakotherapie in der Kinderanästhesie. Anaesth Intensivmed 2012; 53: 330-347
• 8 Kaufmann J, Laschat M, Wappler F. Analgesie und Narkose im Kindesalter. Notfallmedizin up2date 2012; 7: 17-27
• 9 Filho EM, Riechelmann MB. Propofol use in newborns and children: is it safe? A systematic review. J Pediatr (Rio J) 2020; 96: 289-309
• 10 Velly LJ, Rey MF, Bruder NJ. et al. Differential dynamic of action on cortical and subcortical structures of anesthetic agents during induction of anesthesia. Anesthesiology 2007; 107: 202-212
• 11 Mudri M, Williams A, Priestap F. et al. Comparison of drugs used for intubation of pediatric trauma patients. J Pediatr Surg 2020; 55: 926-929
• 12 Bakhtiari E, Mousavi SH, Gharavi Fard M. Pharmacological control of pain during propofol injection: a systematic review and meta-analysis. Expert Rev Clin Pharmacol 2021; 14: 889-899
• 13 Kaufmann J, Becke-Jakob K, Eich C. et al. S2k-Leitlinie 001/033 „Medikamentensicherheit in der Kinderanästhesie“. 2021 Zugriff am 08. Juni 2022 unter: http://www.awmf.org/leitlinien/detail/ll/001–033.html
• 14 Hemphill S, McMenamin L, Bellamy MC. et al. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth 2019; 122: 448-459
• 15 Egan ED, Johnson KB. The influence of hemorrhagic shock on the disposition and effects of intravenous anesthetics: a narrative review. Anesth Analg 2020; 130: 1320-1330
• 16 Yuki K, Lee S, Staffa SJ. et al. Induction techniques for pediatric patients with congenital heart disease undergoing noncardiac procedures are influenced by cardiac functional status and residual lesion burden. J Clin Anesth 2018; 50: 14-17
• 17 Müller-Wirtz LM, Maurer F, Brausch T. et al. Exhaled propofol concentrations correlate with plasma and brain tissue concentrations in rats. Anesth Analg 2021; 132: 110-118
• 18 Hönemann C. Atemkalk: Hinweise zu korrektem Umgang und fachgerechter Nutzung in Rückatemsystemen. Stellungnahme der Kommission für Normung und technische Sicherheit der DGAI. Anaesth Intensivmed 2019; 60: 29-34
• 19 Lerman J. Inhalation agents in pediatric anaesthesia – an update. Curr Opin Anaesthesiol 2007; 20: 221-226
• 20 Moore AD, Anghelescu DL. Emergence delirium in pediatric anesthesia. Paediatr Drugs 2017; 19: 11-20
• 21 Costi D, Cyna AM, Ahmed S. et al. Effects of sevoflurane versus other general anaesthesia on emergence agitation in children. Cochrane Database Syst Rev 2014; (09) CD007084
• 22 Schuster M, Richter H, Pecher S. et al. Positionspapier mit konkreten Handlungsempfehlungen der DGAI und des BDA: Ökologische Nachhaltigkeit in der Anästhesiologie und Intensivmedizin. Anaesth Intensivmed 2020; 61: 329-339
• 23 Cote CJ, Posner KL, Domino KB. Death or neurologic injury after tonsillectomy in children with a focus on obstructive sleep apnea: houston, we have a problem!. Anesth Analg 2014; 118: 1276-1283
• 24 Kamata M, Tobias JD. Remifentanil: applications in neonates. J Anesth 2016; 30: 449-460
• 25 McCann ME, Schouten AN, Dobija N. et al. Infantile postoperative encephalopathy: perioperative factors as a cause for concern. Pediatrics 2014; 133: e751-e757
• 26 van Vonderen JJ, Roest AA, Siew ML. et al. Noninvasive measurements of hemodynamic transition directly after birth. Pediatr Res 2014; 75: 448-452
• 27 De Waal K, Phad N, Lakkundi A. et al. Post-transitional adaptation of the left heart in uncomplicated, very preterm infants. Cardiol Young 2017; 27: 1167-1173
• 28 Agata Y, Hiraishi S, Oguchi K. et al. Changes in left ventricular output from fetal to early neonatal life. J Pediatr 1991; 119: 441-445
• 29 Simma B, Fritz MG, Trawöger R. et al. Changes in left ventricular function in shocked newborns. Intensive Care Med 1997; 23: 982-986
• 30 Bers DM. Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205
• 31 Anderson PA. The heart and development. Semin Perinatol 1996; 20: 482-509
• 32 Burkhardt BE, Rücker G, Stiller B. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease. Cochrane Database Syst Rev 2015; (03) CD009515
• 33 Sassano-Higgins S, Friedlich P, Seri I. A meta-analysis of dopamine use in hypotensive preterm infants: blood pressure and cerebral hemodynamics. J Perinatol 2011; 31: 647-655
• 34 Sümpelmann R, Röher K, Becke-Jakob K. et al. S1-Leitlinie 001/032 „Perioperative Infusionstherapie bei Kindern“. 2021 Zugriff am 08. Juni 2022 unter: http://www.awmf.org/leitlinien/detail/ll/001–032.html
• 35 Kaufmann J, Rascher W, Neubert A. et al. S2k-Leitlinie 027/071: „Medikamentensicherheit bei Kindernotfällen“. 2021 Zugriff am 08. Juni 2022 unter: http://www.awmf.org/leitlinien/detail/ll/027–071.html